Press Release

Morrison & Foerster Elects 14 to Partnership

04 Jan 2011

SAN FRANCISCO (January 4, 2011) – Morrison & Foerster is pleased to announce that 14 lawyers have been elected to the partnership.  Their election is effective January 1, 2011.

“Our newly elected partners reflect the firm’s practice depth and international reach,” said Morrison & Foerster chair Keith Wetmore. “These partners have demonstrated a commitment to client service and legal excellence. We are confident that this talented group of lawyers will make tremendous contributions to our clients’ success and the firm’s progress.”

The following lawyers have been elected Partner:

Charles Chau, a member of the Business Department, resident in the Hong Kong office. Mr. Chau’s practice focuses on mergers and acquisitions, listings and public offerings, capital markets transactions, securities regulatory compliance, joint ventures, and other commercial transactions across Hong Kong, mainland China, and the Asian region. He has extensive experience in a wide variety of industry sectors including banking and financial services, property development, retail, and manufacturing.

Derek F. Foran, a member of the Litigation Department, resident in the San Francisco office.  Mr. Foran specializes in complex commercial actions, has represented numerous public and private companies, and has extensive trial and appellate experience in state and federal courts.

Mark R. S. Foster, a member of the Litigation Department, resident in the San Francisco office.  Mr. Foster specializes in representing public companies, their directors and officers, and board committees in securities class actions, derivative lawsuits, and special investigations.

Linda L. Lane, a member of the Litigation Department, resident in the San Diego office. Ms. Lane’s practice focuses on product liability litigation with an emphasis on consumer products and aviation.  She regularly advises clients regarding product liability issues, including warning and labeling requirements under ANSI, product warranties and recalls, risk assessments, product liability insurance, and product liability claims and defenses in various jurisdictions in anticipation of issues raised in litigation.

Otis Littlefield, a member of the Business Department, resident in the San Francisco office.  Dr. Littlefield's practice focuses on representing life science clients, including biotechnology, pharmaceutical, agricultural biotechnology, and medical device companies. He has expertise in vaccines and adjuvants, stem cell therapeutics, molecular biology, diagnostics, high throughput screening and microarray technologies, gene therapy, bioinformatics, medical devices, and plant molecular biology and breeding.

Kyle W. K. Mooney, a member of the Litigation Department, resident in the New York office. Mr. Mooney has represented clients in complex commercial litigation including patent infringement, trade secrets, antitrust, contractual disputes, and securities fraud.

Daniel P. Muino, a member of the Litigation Department, resident in the San Francisco office. Mr. Muino has significant experience in patent and trademark litigation, representing manufacturers of biomedical devices, computer networking equipment, nano-scale measuring devices, medical claims adjudication software, guitar amplifiers, and other diverse technologies. He also has experience in securities, accounting malpractice, unfair competition, and toxic tort litigation.

Mitchell A. Newmark, a member of the Tax Department, resident in the New York office.  Mr. Newmark’s practice focuses on state and local taxation planning and litigation before administrative and judicial bodies at all levels with respect to income, franchise, gross receipts, and sales and use taxes.

John M. Rafferty, a member of the Business Department, resident in the San Francisco office.  Mr. Rafferty’s practice focuses on corporate finance, mergers and acquisitions, and corporate governance. He has extensive experience in public and private capital-raising transactions, including primary and secondary offerings and private placements. He also represents issuers in mergers, acquisitions, recapitalizations, and exchange offers. His experience covers a range of industries, including telecommunications, technology, life sciences, and retail.

Sylvia Rivera, a member of the Litigation Department, resident in the Los Angeles office.  Ms. Rivera’s practice encompasses a diverse range of complex business litigation, with an emphasis on unfair business practice claims, business torts, and class action defense. She regularly represents clients in the financial services industry, retailers, and insurance companies in actions involving claims of fraud, breach of contract, and violations of Cal. Bus. & Prof. Code 17200 and 17500 and other states' prohibitions on unfair business practices.

Andrew D. Thorpe, a member of the Business Department, resident in the San Francisco office.  Mr. Thorpe’s practice focuses on securities regulation, public offerings, and mergers and acquisitions, as well as corporate governance matters. He has acted as underwriter's counsel or company counsel in public offerings involving companies in a wide variety of industries, including semiconductor, software, life sciences, medical devices, clean technology, financial services, telecommunications, and the Internet.

Mitsutoshi Uchida, a member of the Business Department, resident in the Tokyo office.  Mr. Uchida represents Japanese and non-Japanese clients in various corporate transactions, including debt and equity capital markets transactions, mergers and acquisitions, and financing transactions. He regularly provides advice to financial institutions and investment companies on Japanese regulatory matters.

Janet Xiao, a member of the Business Department, resident in the Palo Alto office. Dr. Xiao primarily represents clients in the biotechnology and pharmaceutical industries in their world-wide patent procurement, patent portfolio management, and strategic planning. She has extensive experience in areas such as nanotechnology, drug delivery systems, therapeutics, diagnostics, and nutraceuticals. Her practice also includes patent reexamination, patent litigation, preparation of freedom-to-operate opinions, and due diligence.

Chie Yakura, a member of the Litigation Department, resident in the Tokyo office. Ms. Yakura represents both non-Japanese and Japanese corporations on a wide range of litigation matters, with an emphasis on intellectual property, technology transactions, and trade secrets, as well as cross-border contractual and commercial disputes. She has also advised on product liability, licensing, antitrust/competition law, corporate restructuring, real estate, and labor and employment matters.

Close

Feedback

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.